Description
The authors state that regulation of cGAS/STING signaling ‘may be a potential target’ but provide no specifics about therapeutic approaches. This represents a critical translational gap between mechanistic understanding and clinical intervention strategies.
Gap type: open_question Source paper: Mitochondrial DNA Leakage and cGas/STING Pathway in Microglia: Crosstalk Between Neuroinflammation and Neurodegeneration. (2024, Neuroscience, PMID:38685462)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:41.569870+00:00”, “resolution_summary”: “Resolved by hypothesis h-var-c4819cffc2: Mitochondrial DNA Release-STING Axis as Senolytic Efficacy Predictor. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-var-c4819cffc2”, “title”: “Mitochondrial DNA Release-STING Axis as Senolytic Efficacy Predictor”, “score”: 0.369, “reason”: “9 token overlaps; entity overlap: dna, sting”, “analysis_id”: “SDA-2026-04-07-gap-debate-20260406-062101-724971bc”, “target_gene”: “CGAS, STING1, MT-DNA”, “target_pathway”: “cGAS-STING, mitochondrial quality control”, “disease”: “molecular biology”, “composite_score”: 0.38, “confidence_score”: 0.375, “status”: “proposed”, “pubmed_evidence_ids”: [“31637803”, “36417500”, “37248315”, “41716413”]}, {“id”: “h-f70d50d17e”, “title”: “Mitochondrial DNA Damage and cGAS-STING Activation Induces Microglial Senescence”, “score”: 0.359, “reason”: “14 token overlaps; entity overlap: dna, sting”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041439-5f43216e”, “target_gene”: “CGAS/STING1/TMEM173”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.52, “confidence_score”: 0.55, “status”: “proposed”, “pubmed_evidence_ids”: [“32424312”, “32661200”, “33149151”]}, {“id”: “h-fca0433042”, “title”: “Microglial IFN-β Priming of Motor Neuron cGAS/STING Amplification”, “score”: 0.251, “reason”: “19 token overlaps; entity overlap: sting”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046”, “target_gene”: “IFNAR1/IFNAR2, STING (TMEM173), cGAS (CGAS)”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.72, “confidence_score”: 0.7, “status”: “proposed”, “pubmed_evidence_ids”: [“30626816”, “30842659”, “32084366”, “32994265”, “preprint”]}, {“id”: “h-6fe30c39bc”, “title”: “STING Antagonists as ALS Therapeutics: Drug Repurposing”, “score”: 0.239, “reason”: “20 token overlaps; entity overlap: sting”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018”, “target_gene”: “STING (TMEM173)”, “target_pathway”: null, “disease”: “neuroinflammation”, “composite_score”: 0.771164, “confidence_score”: 0.68, “status”: “proposed”, “pubmed_evidence_ids”: [“29346698”, “33031745”, “33147677”, “34644542”, “41380972”]}, {“id”: “h-0ac2771e1c”, “title”: “cGAS-STING Pathway Hyperactivation Mediates Tau Propagation”, “score”: 0.229, “reason”: “17 token overlaps; entity overlap: sting”, “analysis_id”: “SDA-2026-04-02-gap-2026-04-01-gap-006”, “target_gene”: “cGAS (CGAS), STING (TMEM173)”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.76, “confidence_score”: 0.76, “status”: “proposed”, “pubmed_evidence_ids”: [“29643778”, “32142648”, “32817599”, “33277574”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046_task_9aae8fc5”, “title”: “While the study establishes TDP-43 triggers mtDNA release via mPTP to activate cGAS/STING, it’s unclear why this pathway preferentially affects motor neurons in ALS when TDP-43 pathology occurs in multiple cell types. Understanding this selectivity is crucial for targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.703, “reason”: “12 token overlaps; entity overlap: dna, pmid, sting”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018_task_73907230”, “title”: “The study identifies cGAS/STING activation as a consequence of TDP-43-mediated mtDNA release, but the temporal dynamics and whether this pathway drives chronic inflammation or acute toxicity remains unclear. This distinction is critical for determining therapeutic timing and approach.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.664, “reason”: “11 token overlaps; entity overlap: dna, pmid, sting”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018”, “quality_score”: 0.73, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062141-739c7f1c_task_9aae8fc5”, “title”: “While the study demonstrates TDP-43 triggers mPTP-mediated mtDNA release, the molecular mechanism by which TDP-43 pathology leads to mPTP opening is not explained. Identifying this upstream trigger could reveal more proximal therapeutic targets than downstream cGAS/STING inhibition.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.649, “reason”: “10 token overlaps; entity overlap: dna, pmid, sting”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062141-739c7f1c”, “quality_score”: 0.772, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2_task_9aae8fc5”, “title”: “While the abstract identifies AQP4 as a ‘potential and promising target’ and mentions it could provide ‘new therapeutic alternatives,’ the specific approaches for therapeutic modulation of AQP4 function are not defined. This represents a critical translational gap for moving from mechanistic understanding to clinical intervention.\n\nGap type: open_question\nSource paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)”, “score”: 0.575, “reason”: “15 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8_20260414-005137”, “title”: “The study shows homozygous R136S fully rescues APOE4-driven pathology while heterozygous provides only partial protection, but the mechanistic basis for this gene dosage effect is unexplained. Understanding this mechanism is critical for developing therapeutic strategies that could mimic R136S protection.\n\nGap type: unexplained_observation\nSource paper: The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. (2023, Nature neuroscience, PMID:37957317)”, “score”: 0.492, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}